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ational guidelines do not support preoperative 
body washing to reduce surgical site infections, 
instead recommending bathing or showering 
with soap. Yet preoperative body washing continues to 
be widely used in many hospitals across Europe. This 
paper suggests that existing trials of preoperative body 
washing, upon which guidelines are based, are dated 
and proposes a new investigation of preoperative body 
washing using modern definitions of surgical site infec-
tion with standardised patient follow up, modern surgical 
techniques and well designed trials. This paper provides 
a critique of existing guidelines and describes a ran-
domised trial with 60 participants to compare the effect 
of soap and two antiseptic washing products on colony 
forming units (CFUs) for up to six hours. Chlorhexidine 
gluconate and octenidine were significantly more effec-
tive than soap in reducing CFUs in the underarm, and 
chlorhexidine was significantly more effective than soap 
in reducing CFUs in the groin.
Introduction
The concept of preoperative body washing; washing with an anti-
septic solution before surgery, was introduced over 30 years ago with 
the aim of reducing skin bacterial load and ultimately reducing 
endogenous surgical site infections (SSIs) (Cruse and Foord, 1980). 
Despite guidelines (NICE, 2008) and systematic reviews (Webster 
and Osborne, 2011) that do not support this practice, preoperative 
body washing is routine in some hospitals in Europe, especially in the 
UK, Sweden and the Netherlands. It is unusual for a clinical interven-
tion with an associated cost to continue to be widely used in contra-
diction to national guidelines. This situation calls for a reappraisal of 
the effectiveness of preoperative body washing.
Literature review
Probably the two most influential documents in the UK which discuss 
preoperative body washing are the SSI guidelines published by the 
National Institute for Health and Clinical Excellence (NICE, 2008)   
and the Cochrane systematic review of body washing (Webster   
and Osborne, 2011). Based upon a review of the evidence neither of 
these documents recommends preoperative body washing. The NICE 
guidelines recommend that patients shower or bathe using soap 
either the day before or the day of surgery and the Cochrane review 
found no clear evidence to support or reject preoperative body wash-
ing. However, examination of the evidence included in these docu-
ments identifies some potential concerns. For example, the NICE 
recommendation is based on a meta analysis of five trials published 
between 20 and 29 years ago (Byrne et al, 1992; Earnshaw et al, 1989; 
Hayek et al, 1987; Randall et al, 1983; Rotter et al, 1988). The age of 
the trials is important as they pre-date standardised definitions of SSIs 
and surveillance protocols and developments within clinical practice, 
such as the introduction of routine antibiotic prophylaxis (Horan et al, 
1992). It is interesting to note the comparatively high SSI rates in the 
included trials, ranging from 10%–50%.
Of further interest is that while this meta-analysis led NICE to   
recommend the use of soap, only three (Earnshaw et al, 1989; Hayek   
et al, 1987; Randall et al, 1983) of the five studies included in the meta-
analysis used soap as a comparison group, with the remaining studies 
comparing an antiseptic agent against a detergent. Additionally, one study 
(Hayek et al, 1987), which compared soap, detergent and an antiseptic 
was flawed. In the flawed study it was subsequently discovered that the 
‘detergent’ had antimicrobial properties, yet the contaminated data from 
patients receiving the ‘detergent’ is still included in the meta-analysis.
The same five trials are included in the Cochrane systematic review 
of preoperative bathing or showering, although they are separated 
into trials comparing antiseptic solutions against soap and trials com-
paring antiseptic solutions against detergent. Three trials (Earnshaw   
et al, 1989; Hayek et al, 1987; Randall et al, 1983) are included in the 
meta-analysis comparing antiseptic solutions (chlorhexidine gluco-
nate) against soap. One trial from 1983 with 62 participants and a 
patient follow up of seven days found no difference in SSI rates 
(Randall et al, 1983). A second trial from 1989 with 66 participants 
and a patient follow up of around five days found in favour of soap 
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(Earnshaw et al, 1989). The third trial with 1315 patients followed up 
for six weeks (Hayek et al, 1987). This large trial established superior 
performance for chlorhexidine with an infection rate in the chlorhex-
idine group of 9% compared to 13% for the soap group. However, this 
statistical significance was lost when the trial was combined in a 
meta-analysis with the two small studies using a random effects 
model (p value 0.94), notably heterogeneity remained high (I2 =60%).
The limitations of these trials suggests that a new study using 
modern definitions, modern clinical practice and high quality design 
is required.
We therefore proposed a two stage study which would address the 
deficits of the existing studies and allow a comparison of soap against 
antiseptic agents. The first stage was to identify the effect of preop-
erative body washing on skin bacterial counts and the second stage 
was to identify the effect of preoperative body washing on surgical 
site infections. Splitting the study into two stages was a necessary 
step for ethical reasons. If a randomised trial of body washing showed 
no difference in skin bacterial counts, then it would be pointless to 
conduct a large expensive trial involving patients to measure SSI rates. 
Conversely, if a trial of body washing showed a difference in skin 
bacterial counts in favour of antiseptics then a trial measuring SSIs 
would be justified. This paper describes the first stage of the study.
Aim of the study
The aim of the first stage of the study reported in this paper was to 
measure the immediate and residual effect of two body washing anti-
septic products against soap with colony forming units as the out-
come measure.
Materials and methods
We undertook a randomised controlled trial with plain soap, chlorhex-
idine gluconate and octenidine comparing the reduction in colony 
forming units in 60 healthy volunteers.
Following ethical approval from the University Research Ethics 
Committee and with consent, 60 participants were randomised to 
shower with one of the following products;
  Plain liquid soap (Morrisons)
  HiBi Scrub Plus (4% w/v chlorhexidine gluconate, Molnlycke 
Health Care)
  Octenisan (1% octenidine dihydrochloride, Schulke)
In accordance with manufacturers’ instructions, chlorhexidine gluconate 
was used once a day for two consecutive days and octenidine was used 
once a day for five consecutive days. Body contact time for chlorhexidine 
gluconate was one minute compared to three minutes for octenidine. As 
there were no manufacturers’ instructions for plain soap we matched the 
soap application method with the chlorhexidine method. The method of 
application was also taken from the manufacturers’ instructions.
Sample size
A pragmatic decision was taken to recruit 60 participants. Volunteers 
were recruited until 60 participants completed the study. Drop out 
rates are reported and missing data is accounted for.
Recruitment method and exclusion criteria
University students and staff volunteers were recruited through flyers. 
Volunteers who responded to recruitment and met the inclusion and 
exclusion criteria were accepted onto the study. Inclusion criterion 
was access to a shower. Exclusion criteria were as follows:
  Allergies to ingredients in the soap, HiBi Scrub Plus or Octenisan 
products
  Open wounds
  Antibiotics currently or in previous week
  Respiratory infection
  Skin infection
  Jewellery in nose
Risk of bias
Randomisation sequence was generated using block randomisation 
with multiples of three. Group allocation details were placed inside 
sequentially numbered sealed envelopes. The researchers overseeing 
baseline data collection were aware of each participant’s group alloca-
tion status, but laboratory staff were blinded to this.
Outcome measures
Anonymous demographic data were collected to validate the randomisa-
tion. Baseline swabs were taken before body washing commenced, 
immediately after the final shower and then again at four hours and six 
hours. Swab samples were taken from the nostrils, underarms and groin. 
Rayon tipped swabs were pressed firmly against the skin and rotated. At 
the end of the study, participants were also asked if the product had 
caused any skin conditions, such as redness, itchiness or dryness.
Laboratory methods
Before the study commenced, each stage of bacterial sampling 
method was tested in the laboratory. This included bacterial controls, 
swab selection, neutraliser tests and the study sampling protocol.
Controls
Control experiments using a mixed culture of Staphylococcus aureus 
ATCC 6538 (S. aureus), Staphylococcus warneri NCTC 7291 (S. war-
neri) and Escherichia coli ATCC 10536 (E. coli) were conducted to 
validate the test methods. Experiments were performed independently 
on at least three occasions.
Swab selection
Recovery of micro-organisms from Amies charcoal transport swabs 
(Technical Services Consultants) was compared to use of Sterilin rayon 
tipped plain sterile swabs (Fisher Scientific) and neutraliser. Recovery 
of micro-organisms using the rayon tipped swab and neutraliser 
method was equivalent to that achieved with charcoal media, so this 
method was adopted for the study as it was more cost effective.
Validation of non-toxicity of neutraliser
The purpose of this test was to show that the solution in which swabs 
were transported did not kill any bacteria present on the swabs. Monocul-
tures of S. aureus, S. warneri and E. coli were grown overnight (18 hours) 
at 37ºC in 10 mL of casein soya bean digest broth (Oxoid) in an incubator 
shaking at 100 rpm. The overnight cultures were centrifuged at 4000 rpm 
for 10 minutes and resuspended in 10 mL of sterile phosphate buffered 
saline (PBS) to remove the culture media. 5 mL of each organism were 
pooled together to make 15 mL of mixed culture test suspension.
Sterilin rayon tipped swabs were dipped into the mixed culture test 
suspension and pressed gently against the side to the container to 
remove excess. The tip of each swab was cut off using scissors into a 
universal containing 10 mL of either sterile neutraliser or PBS. This 
inoculated neutraliser and PBS was stored at room temperature for 
one hour (to simulate the maximum transportation time to the labora-
tory) and then at 4ºC for a further two hours (three hours storage in 
total). Universals were vortexed briefly, then aliquots were taken at 
zero, one, two and three hours and serially diluted in PBS before enu-
meration using the spread plate technique on casein soya bean digest 
agar (Oxoid). The neutraliser was not toxic to the control micro-
organisms over a three hour period (one hour at room temperature 
and two hours at 4ºC), giving similar survival to organisms in phos-
phate buffered saline under the same conditions.
Validation of neutraliser efficacy
The purpose of this test was to show that the solution in which   
swabs were transported was effective in preventing any product (soap, 
HiBi Scrub Plus or Octenisan) from continuing to act on bacteria.   
0.1 mL of each test product was added to 9 mL of sterile neutraliser and 
0.9 mL of sterile distilled water to give a final concentration of 30g/L 
tween 80 and 3g/L soya bean lecithin. The solution was vortexed to mix VOL. 13  NO. 1  January 2012  Journal of Infection Prevention  13
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thoroughly and then immediately inoculated with a swab that had been 
dipped in a mixed culture test suspension (as detailed previously). The 
inoculated universals containing neutraliser, product mixture and bacte-
ria were stored at room temperature for one hour (to simulate the maxi-
mum transportation time to the laboratory) and then at 4ºC for a further 
two hours (three hours storage in total). Universals were vortexed briefly, 
then aliquots were taken at zero, one, two and three hours and serially 
diluted in PBS before enumeration using the spread plate technique on 
casein soya bean digest agar. An aqueous solution of 30 g/L tween 80 
(Fisher Scientific) and 3 g/L soya bean lecithin (BDH) in PBS dubecco A 
pH 7.3 (Oxoid), was effective in neutralising the activity of 1 in 100 dilu-
tions of all test products. This dilution factor is far less than the predicted 
in-use dilution, assuming that volunteers use 30 mL of product and 
shower for five minutes using 17.5 L of water (data obtained from the 
Environment Agency for a low performance 7.2 kW electric shower).
Laboratory test protocol
Neutraliser solutions containing the rayon tips of volunteer swabs were 
transported to the microbiology laboratory and refrigerated to 4ºC within 
one hour of sample collection. Aliquots were taken within the validated 
three hour time limit and serially diluted in PBS before enumeration using 
the spread plate technique on casein soya bean digest agar. All Petri-
dishes were incubated for 72 hours at 37ºC, as preliminary testing 
showed that the number of colonies present on the agar reached a max-
imum at this time point. The number of colony forming units originally 
present on the volunteers’ swabs was then calculated. Because of the 
limit of sensitivity of the spread plate method, the minimum number of 
colony forming units that could be detected was 50 per swab.
Statistical analysis
A repeated measures ANOVA was used to compare the difference in 
average log reduction of colony forming units per swab between the 
three groups from pre-intervention to the three post-intervention time 
points. These tests were carried out separately for the three swab sites.
Results
Sixty participants completed the study over a period of two months. 
One participant failed to complete the final swab sample and was 
replaced. The laboratory results for two participants were contami-
nated and these participants were also replaced. None of the partici-
pants reported any skin irritations.
Participant demographics
The p value for the chi-squared statistic showed a similar distribution 
by gender within each group (0.928) and there was no evidence of a 
difference in age distribution (p 0.564).
Analysis for underarm
Analysis of Figure 1 shows there is a significant difference between 
the products (p=0.007) (not shown). These differences are evident in 
Table 1 with a significant difference between soap and HiBi Scrub 
Plus (p=0.011) and also between soap and Octenisan (p=0.004). In 
summary for the underarm, there is significant evidence of a differ-
ence in log counts between soap and the two antiseptic products, 
and the drop in counts is significant at hours four and six (p=0.024) 
(not shown).
Figure 1.  Difference between product type over time for underarm.1 = Baseline, 2 = 0 
hours post-intervention, 3 = 4 hours post-intervention and 4 = 6 hours post-intervention
Table 1.  Differences between products for underam
Contrast results (K Matrix)
  Averaged Variable
Product Simple Contrast a MEASURE_1
HiBi Scrub Plus vs. soap Contrast estimate −0.769
  Hypothesized value 0
  Difference (estimate - hypothesized) −0.769
  Std. Error 0.291
  Sig. 0.011
  95% confidence interval Lower Bound −1.351
  for difference Upper Bound −0.186
Octenisan vs. soap Contrast estimate −0.858
  Hypothesized value 0
  Difference (estimate - hypothesized) −0.858
  Std. Error 0.284
  Sig. 0.004
  95% confidence interval Lower Bound −1.426
  for difference Upper Bound −0.290
a. Reference category = soap14  Journal of Infection Prevention  January 2012  VOL. 13  NO. 1
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Analysis for groin
Figure 2 shows the differences between soap, HiBi Scrub Plus and 
Octenisan. These differences are shown in Table 2 with a significant 
effect between soap and HiBi Scrub Plus (p=0.000) but not between 
soap and Octenisan (p=0.212). In summary for the groin, there is 
significant evidence of a difference in log counts between HiBi Scrub 
Plus and the other two products, and the drop in counts is significant 
at hours four and six (p=0.000) (not shown).
Analysis for nose
Figure 3 does not show enough evidence for a difference in product 
types (p=0.458) (not shown). There is not enough evidence to sug-
gest a difference in log counts between the three products.
Limitation
A limitation of this study was that participants took their own swab 
samples although this was conducted after a training session from the 
Figure 2.  Difference between product type over time for groin. 1 = Baseline, 2 = 0 hours 
post-intervention, 3 = 4 hours post-intervention  and 4 = 6 hours post-intervention
Table 2.  Differences between products for groin
Contrast results (K Matrix)
  Averaged Variable
Product Simple Contrast a MEASURE_1
HiBi Scrub Plus vs. soap Contrast estimate −1.118
  Hypothesized value 0
  Difference (estimate - hypothesized) −1.118
  Std. Error 0.256
  Sig. 0.000
  95% confidence interval Lower Bound −1.632
  for difference Upper Bound −0.604
Octenisan vs. soap Contrast estimate −0.316
  Hypothesized value 0
  Difference (estimate - hypothesized) −0.316
  Std. Error 0.250
  Sig. 0.212
  95% confidence interval Lower Bound −0.817
  for difference Upper Bound 0.185
a. Reference category = soap
researcher and it was not possible to check participants’ showering 
technique.
Discussion
New studies using rigorous methods of SSI surveillance for 30 days 
are identifying infection rates which are considerably higher than 
existing data (Tanner et al, 2009). This, in conjunction with the high 
cost of SSIs, has led to a renewed focus on interventions to reduce 
surgical site infections (House of Commons Public Accounts Com-
mittee, 2009). Preoperative body washing is a relatively inexpensive 
intervention and therefore should be assessed properly before it is 
dismissed as having no additional benefit over soap.
This small well conducted trial shows that preoperative body washing 
products, especially chlorhexidine, are more effective than soap in 
reducing colony forming units on the skin of healthy volunteers. This 
effect is seen immediately after showering and also six hours after show-
ering. Chlorhexidine was found to be more effective than octendine, 
Figure 3.  Difference between product type over time for nose. 1 = Baseline, 2 = 0 hours 
post-intervention, 3 = 4 hours post-intervention  and 4 = 6 hours post-interventionVOL. 13  NO. 1  January 2012  Journal of Infection Prevention  15
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however this was just in the groin. Though the recommended five day 
application for Octenisan compared with just two days for HiBi Scrub 
Plus may make this product less appealing to patients.
We are not aware of any studies which demonstrate the relationship 
between colony forming units and surgical site infections. However, 
the effect of body washing on colony forming units observed in this 
study means the possibility exists for body washing to have an effect 
on surgical site infections. The second stage of this investigation is to 
conduct a randomised controlled trial among surgical patients com-
paring soap against a preoperative body wash with antiseptic and 
measuring SSI as the outcome.
To provide definitive level 1 evidence which can be incorporated 
into preoperative body washing guidelines a meta-analysis of   
several clinical trials is needed. To be eligible to be included in a 
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meta-analysis, clinical trials should meet certain key require-
ments. These are listed below.
  Use showering rather than bathing (as per manufacturers’ 
instructions)
  Use defined washing protocols – application method, number of 
applications
  Use standard definitions of surgical site infections
  Be conducted among a single surgical group of patients
  Follow the CONSORT statement when disseminating results to 
ensure high quality trial reporting (Moher et al, 2001)
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